Department of Medicine, Section of Hematology, Stem Cell Research Laboratory, University of Verona, Verona, Italy.
Blood Cancer J. 2012 May;2(5):e73. doi: 10.1038/bcj.2012.17. Epub 2012 May 25.
Stromal cells are essential components of the bone marrow (BM) microenvironment that regulate and support the survival of different tumors, including chronic lymphocytic leukemia (CLL). In this study, we investigated the role of Notch signaling in the promotion of survival and chemoresistance of human CLL cells in coculture with human BM-mesenchymal stromal cells (hBM-MSCs) of both autologous and allogeneic origin. The presence of BM-MSCs rescued CLL cells from apoptosis both spontaneously and following induction with various drugs, including Fludarabine, Cyclophosphamide, Bendamustine, Prednisone and Hydrocortisone. The treatment with a combination of anti-Notch-1, Notch-2 and Notch-4 antibodies or γ-secretase inhibitor XII (GSI XII) reverted this protective effect by day 3, even in presence of the above-mentioned drugs. Overall, our findings show that stromal cell-mediated Notch-1, Notch-2 and Notch-4 signaling has a role in CLL survival and resistance to chemotherapy. Therefore, its blocking could be an additional tool to overcome drug resistance and improve the therapeutic strategies for CLL.
基质细胞是骨髓(BM)微环境的重要组成部分,调节并支持包括慢性淋巴细胞白血病(CLL)在内的不同肿瘤的存活。在这项研究中,我们研究了 Notch 信号通路在促进人与自体和异体来源的骨髓间充质基质细胞(hBM-MSCs)共培养的人 CLL 细胞存活和化疗耐药性方面的作用。BM-MSCs 的存在挽救了 CLL 细胞的凋亡,无论是自发的还是在各种药物诱导下,包括氟达拉滨、环磷酰胺、苯达莫司汀、泼尼松和氢化可的松。用抗 Notch-1、Notch-2 和 Notch-4 抗体或 γ-分泌酶抑制剂 XII(GSI XII)联合治疗可在第 3 天逆转这种保护作用,即使存在上述药物也是如此。总的来说,我们的研究结果表明,基质细胞介导的 Notch-1、Notch-2 和 Notch-4 信号通路在 CLL 存活和对化疗的耐药性方面发挥作用。因此,阻断它可能是克服耐药性和改善 CLL 治疗策略的另一种手段。